Financial Ratios Venus Concept Inc.
Stocks
VERO
US92332W3034
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3105 USD | +2.56% |
|
-.--% | -79.02% |
| 05-13 | Venus Concept Inc. Announces Senior Management Changes | CI |
| 04-08 | Venus Concept Inc. announced that it has received $1.5 million in funding | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | -10.83 | -6.97 | -15.42 | -16.16 | -21 | ||||
Return on Total Capital | -14.07 | -9.03 | -20.57 | -22.29 | -30.31 | ||||
Return On Equity % | -137.53 | -51.88 | -173.18 | 1.57K | 885.33 | ||||
Return on Common Equity | -144.02 | -54.04 | -178.24 | 1.26K | 806.8 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 65.87 | 70.15 | 66.3 | 68.32 | 68.34 | ||||
SG&A Margin | 95 | 78.94 | 90.35 | 94.66 | 99.95 | ||||
EBITDA Margin % | -32.91 | -12.01 | -30.57 | -31.69 | -35.93 | ||||
EBITA Margin % | -34.61 | -13.32 | -31.56 | -32.53 | -36.57 | ||||
EBIT Margin % | -39.07 | -16.61 | -35.05 | -37.08 | -41.93 | ||||
Income From Continuing Operations Margin % | -106.16 | -20.96 | -43.8 | -48.52 | -72.45 | ||||
Net Income Margin % | -104.73 | -21.79 | -43.92 | -48.79 | -72.49 | ||||
Net Avail. For Common Margin % | -109.3 | -21.79 | -43.92 | -48.79 | -72.49 | ||||
Normalized Net Income Margin | -29.62 | -15.65 | -27.02 | -28.84 | -34.94 | ||||
Levered Free Cash Flow Margin | -31.09 | -4.26 | -15.43 | -12.68 | -7.52 | ||||
Unlevered Free Cash Flow Margin | -24.4 | -1.33 | -12.57 | -7.04 | -0.14 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.44 | 0.67 | 0.7 | 0.7 | 0.8 | ||||
Fixed Assets Turnover | 19.06 | 34.03 | 19.16 | 11.26 | 12.89 | ||||
Receivables Turnover (Average Receivables) | 1.4 | 2.12 | 2.36 | 2.3 | 2.71 | ||||
Inventory Turnover (Average Inventory) | 1.45 | 1.65 | 1.51 | 1.03 | 1.01 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 3.55 | 3.43 | 2.12 | 2.13 | 1.6 | ||||
Quick Ratio | 2.79 | 2.58 | 1.29 | 1.15 | 0.78 | ||||
Operating Cash Flow to Current Liabilities | -0.88 | -0.63 | -0.68 | -0.41 | -0.37 | ||||
Days Sales Outstanding (Average Receivables) | 262.11 | 172.24 | 154.4 | 158.74 | 135.13 | ||||
Days Outstanding Inventory (Average Inventory) | 251.6 | 221.71 | 241.96 | 354.47 | 362.25 | ||||
Average Days Payable Outstanding | 112.67 | 59.76 | 81.39 | 133.41 | 189.17 | ||||
Cash Conversion Cycle (Average Days) | 401.05 | 334.19 | 314.98 | 379.8 | 308.21 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 185.79 | 187.2 | 958.64 | -592.59 | 1.52K | ||||
Total Debt / Total Capital | 65.01 | 65.18 | 90.55 | 120.3 | 93.81 | ||||
LT Debt/Equity | 181.9 | 185.9 | 849.44 | -549.87 | 1.18K | ||||
Long-Term Debt / Total Capital | 63.65 | 64.73 | 80.24 | 111.63 | 72.9 | ||||
Total Liabilities / Total Assets | 72.74 | 72.97 | 93.03 | 114.36 | 95.84 | ||||
EBIT / Interest Expense | -3.65 | -3.54 | -7.65 | -4.11 | -3.55 | ||||
EBITDA / Interest Expense | -2.84 | -2.56 | -6.18 | -3.23 | -2.85 | ||||
(EBITDA - Capex) / Interest Expense | -2.88 | -2.66 | -6.26 | -3.25 | -2.87 | ||||
Total Debt / EBITDA | -3.43 | -6.14 | -2.97 | -3.58 | -1.97 | ||||
Net Debt / EBITDA | -1.98 | -3.7 | -2.56 | -3.34 | -1.77 | ||||
Total Debt / (EBITDA - Capex) | -3.39 | -5.9 | -2.94 | -3.56 | -1.96 | ||||
Net Debt / (EBITDA - Capex) | -1.96 | -3.56 | -2.53 | -3.32 | -1.76 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | -29.34 | 35.39 | -5.8 | -23.26 | -15.09 | ||||
Gross Profit, 1 Yr. Growth % | -32.96 | 44.18 | -10.96 | -20.92 | -15.07 | ||||
EBITDA, 1 Yr. Growth % | -9.08 | -50.58 | 139.7 | -20.45 | -3.72 | ||||
EBITA, 1 Yr. Growth % | -7.72 | -47.9 | 123.21 | -20.91 | -4.53 | ||||
EBIT, 1 Yr. Growth % | 0.66 | -42.44 | 98.81 | -18.83 | -3.97 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 95.81 | -73.27 | 96.85 | -14.99 | 26.78 | ||||
Net Income, 1 Yr. Growth % | 101.15 | -71.83 | 89.89 | -14.76 | 26.16 | ||||
Normalized Net Income, 1 Yr. Growth % | -2.84 | -28.46 | 62.6 | -18.1 | 2.89 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | -51.15 | -81.87 | 56.8 | -31.14 | 4 | ||||
Accounts Receivable, 1 Yr. Growth % | -10.53 | -11.08 | -20.58 | -21.77 | -35.78 | ||||
Inventory, 1 Yr. Growth % | -5.76 | 15.68 | 16.37 | -3.49 | -23.89 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | -23.86 | -24.58 | 189.21 | -24.36 | -27.76 | ||||
Total Assets, 1 Yr. Growth % | -16.01 | -4.15 | -20.33 | -25.3 | -27.2 | ||||
Tangible Book Value, 1 Yr. Growth % | 4.01 | 0.72 | -114.97 | 487.17 | -88.41 | ||||
Common Equity, 1 Yr. Growth % | -40.37 | -7.44 | -80.23 | -273.22 | -116.9 | ||||
Cash From Operations, 1 Yr. Growth % | -27.64 | -30.99 | 36.46 | -52.34 | -13.94 | ||||
Capital Expenditures, 1 Yr. Growth % | -74.09 | 75.94 | -34.38 | -65.48 | 6.03 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | 15.71 | -80.02 | 240.92 | -36.95 | -49.63 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 18.58 | -91.88 | 788.4 | -57.02 | -98.29 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | -12.81 | -2.19 | 12.93 | -14.98 | -19.28 | ||||
Gross Profit, 2 Yr. CAGR % | -19.53 | -1.68 | 13.3 | -16.09 | -18.05 | ||||
EBITDA, 2 Yr. CAGR % | 102.3 | -32.97 | 8.84 | 38.09 | -12.48 | ||||
EBITA, 2 Yr. CAGR % | 124.02 | -30.66 | 7.84 | 32.86 | -13.11 | ||||
EBIT, 2 Yr. CAGR % | 148.56 | -23.88 | 6.97 | 27.03 | -11.71 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 141.42 | -27.65 | -27.46 | 29.36 | 3.81 | ||||
Net Income, 2 Yr. CAGR % | 133.71 | -24.73 | -26.87 | 27.23 | 3.7 | ||||
Normalized Net Income, 2 Yr. CAGR % | 174.86 | -16.63 | 7.86 | 15.4 | -8.2 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -14.14 | -70.24 | -46.68 | 3.92 | -19.3 | ||||
Accounts Receivable, 2 Yr. CAGR % | 11.21 | -10.81 | -15.96 | -21.18 | -29.12 | ||||
Inventory, 2 Yr. CAGR % | -6.38 | 4.41 | 16.02 | 5.98 | -14.29 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.31 | -24.22 | 47.69 | 47.91 | -26.08 | ||||
Total Assets, 2 Yr. CAGR % | 13.26 | -10.28 | -11.62 | -22.86 | -26.26 | ||||
Tangible Book Value, 2 Yr. CAGR % | 1.59 | 2.35 | -61.16 | -6.23 | -17.5 | ||||
Common Equity, 2 Yr. CAGR % | 16.78 | -25.71 | -57.23 | -41.48 | -45.9 | ||||
Cash From Operations, 2 Yr. CAGR % | -7.73 | -29.34 | -2.96 | -19.35 | -35.96 | ||||
Capital Expenditures, 2 Yr. CAGR % | -49.81 | -32.48 | 7.45 | -52.4 | -39.5 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 49.7 | -53.64 | -17.48 | 46.62 | -43.65 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 59.63 | -70.39 | -15.06 | 95.4 | -91.42 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | -4.32 | 0.97 | -3.41 | -0.71 | -15.01 | ||||
Gross Profit, 3 Yr. CAGR % | -9.01 | -2.26 | -4.88 | 0.5 | -15.75 | ||||
EBITDA, 3 Yr. CAGR % | 23.99 | 26.47 | 2.5 | -1.96 | 22.45 | ||||
EBITA, 3 Yr. CAGR % | 28.25 | 37.76 | 2.38 | -2.75 | 19 | ||||
EBIT, 3 Yr. CAGR % | 33.53 | 52.64 | 4.83 | -2.43 | 15.72 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 123.64 | 15.93 | 1.01 | -23.52 | 28.49 | ||||
Net Income, 3 Yr. CAGR % | 142.55 | 15.44 | 2.47 | -23.04 | 26.87 | ||||
Normalized Net Income, 3 Yr. CAGR % | 91.08 | 75.49 | 4.17 | -1.6 | 11.07 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 119.61 | -48.87 | -48.21 | -41.93 | 0.71 | ||||
Accounts Receivable, 3 Yr. CAGR % | 20.85 | 3.22 | -14.19 | -17.94 | -26.38 | ||||
Inventory, 3 Yr. CAGR % | 10.02 | 0.46 | 8.25 | 9.12 | -5.09 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.65 | -7.58 | 18.42 | 18.16 | 16.48 | ||||
Total Assets, 3 Yr. CAGR % | 16.63 | 7.13 | -13.11 | -16.44 | -24.33 | ||||
Tangible Book Value, 3 Yr. CAGR % | -14.05 | 1.3 | -46.07 | -3.97 | -53.29 | ||||
Common Equity, 3 Yr. CAGR % | 3.46 | 8.08 | -52.22 | -31.82 | -61.32 | ||||
Cash From Operations, 3 Yr. CAGR % | 14.91 | -16.24 | -12 | -23.44 | -17.59 | ||||
Capital Expenditures, 3 Yr. CAGR % | -42.45 | -23.75 | -33.12 | -26.4 | -37.84 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | -25.33 | -9.85 | -24.56 | 2.68 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | -42.67 | -7.99 | -32.32 | -59.72 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 14.73 | 2.24 | -5.74 | -10.1 | ||||
Gross Profit, 5 Yr. CAGR % | - | 12.91 | -0.66 | -8.05 | -10.38 | ||||
EBITDA, 5 Yr. CAGR % | - | 16.34 | 17.69 | 30.99 | -3.78 | ||||
EBITA, 5 Yr. CAGR % | - | 16.8 | 19.66 | 35.78 | -4.12 | ||||
EBIT, 5 Yr. CAGR % | - | 22.07 | 22.2 | 41.83 | -2.13 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 12.13 | 42.55 | 21.13 | 2.12 | ||||
Net Income, 5 Yr. CAGR % | - | 12.8 | 50.15 | 20.02 | 2.96 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 20.38 | 52.01 | 48.4 | -0.97 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | -18.34 | 24.67 | -32.1 | -38.15 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | - | 4.51 | -7.33 | -20.51 | ||||
Inventory, 5 Yr. CAGR % | - | - | 12.38 | 2.63 | -1.4 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 19.42 | 11.55 | -1.92 | ||||
Total Assets, 5 Yr. CAGR % | - | - | 4.38 | -5.63 | -18.63 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | - | -37.45 | -1.78 | -36.07 | ||||
Common Equity, 5 Yr. CAGR % | - | - | -27.33 | -15.44 | -49.78 | ||||
Cash From Operations, 5 Yr. CAGR % | - | -2.75 | 7.4 | -17.5 | -22.51 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | -12.51 | -26.12 | -36.85 | -35.75 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | -2.2 | -25.29 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | -6.37 | -64.39 |
- Stock Market
- Stocks
- VERO Stock
- Financials Venus Concept Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















